-

HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity

ABEC stainless steel fermentation solutions to enhance HEC Pharm’s manufacturing productivity and flexibility

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC Pharm’s manufacturing site in Guangzhou, China. The stainless-steel fermenter trains are custom designed to support HEC Pharm’s scale-up initiative of their advanced insulin products.

HEC Pharm is a leader in producing innovative medicines, generics, and biologics. To ensure the highest productivity and product quality, HEC Pharm selected ABEC for its long-term experience in fermenter design and scale up. ABEC has successfully delivered thousands of customized bioreactor and fermentation solutions for over 45 years. ABEC’s 32,000m2 of manufacturing space, the largest global capacity in the industry, also ensures timely delivery to meet HEC Pharm’s rapid time to market needs.

“HEC Pharm is committed to bringing high-quality advanced insulin products to the global market,” said Richard Tang, President of HEC R&D Center. “We are now able to seamlessly scale up from existing processes, which is critical to our plans for continuous growth.”

“ABEC has supported the rapid growth of China’s biotech industry for over ten years,” said Scott Pickering, ABEC CEO and Chairman. “We value the opportunity to work with HEC Pharm as they strive to bring essential medicines to a larger global market.”

About ABEC

Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. The majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. To learn more about ABEC, visit abec.com, email info@abec.com, or follow on LinkedIn.

About HEC

HEC Pharm was established in 2002. Today HEC Pharm includes 4 subsidiaries with manufacturing facilities. HEC Pharm has become one of the most innovative and promising pharmaceutical companies in China. If you are interested in more information on our products, clinical studies and our research, or you are looking for any business cooperation opportunities, contact us.

Contacts

Susan Cooper-Curcio, scurcio@abec.com, +1 (610) 861 4666

ABEC LogoABEC Logo

ABEC


Release Summary
ABEC large-scale stainless-steel fermentation solutions to enhance HEC Pharm’s manufacturing productivity and flexibility.

Contacts

Susan Cooper-Curcio, scurcio@abec.com, +1 (610) 861 4666

More News From ABEC

ABEC Unveils Breakthrough Single Use Bioreactor Technology for Cell Therapy Manufacturing

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from bench to commercial scale. The ATB™ redefines cell culture by mimicking the h...

ABEC Introduces 5 Year Warranty for CSR® Single-Use Systems Products

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a leader in engineered solutions and services for biotech manufacturing, today announced a 5-year warranty for its Custom Single Run (CSR®) single-use systems products. The 5-year warranty is unprecedented in the bioprocess systems industry and is effective immediately for all new purchases of CSR equipment. Since its inception almost 50 years ago, ABEC has been renowned for the quality and reliability of its products. ABEC has dozens of systems that have...

Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR®) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland. ABEC’s large-scale CSR Bioreactors will be at the heart of the facility, and ABEC will also manufacture, test, and install large-scale CSR GenMix systems. Equipment deliveries are scheduled for Q3 2023. Lilly selec...
Back to Newsroom